SCHEMBL9380892

SCHEMBL9380892

Cc1cc(F)cc2[nH]c(=O)oc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 4/20 0.42
NOS2 P35228 3/20 0.42
NOS3 P29474 2/20 0.42
GRIN2D O15399 3/20 0.39
GRIN3B O60391 3/20 0.39
GRIN1 Q05586 3/20 0.39
GRIN2A Q12879 3/20 0.39
GRIN2B Q13224 3/20 0.39
GRIN2C Q14957 3/20 0.39
GRIN3A Q8TCU5 3/20 0.39
KDM4E B2RXH2 1/20 0.38
KMO O15229 1/20 0.36
OGT O15294 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
ADRA2A P08913 1/20 0.34
TSHR P16473 1/20 0.34
THPO P40225 1/20 0.34
BLM P54132 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9380463 0.82 KMO (0.37) NOS1NOS2NOS3KDM4EKMO
SCHEMBL30468841 0.82 KMO (0.37) NOS1NOS2NOS3KDM4EKMO
SCHEMBL27474482 0.80 AR (0.42) NOS1NOS2NOS3GRIN2DGRIN3B
SCHEMBL2149212 0.80 NOS1 (0.53) NOS1NOS2NOS3GRIN2DGRIN3B
SCHEMBL24207806 0.79 KMO (0.35) NOS1NOS2NOS3KDM4EKMO
SCHEMBL24512761 0.78 CREBBP (0.34) NOS1NOS2NOS3KDM4EKMO
SCHEMBL16362079 0.77 NOS1 (0.42) NOS1NOS2NOS3GRIN2DGRIN3B
SCHEMBL4878589 0.77 NOS1 (0.46) NOS1NOS2NOS3GRIN2DGRIN3B
SCHEMBL30445055 0.77 NOS1 (0.42) NOS1NOS2NOS3GRIN2DGRIN3B
SCHEMBL18415160 0.77 NOS1 (0.42) NOS1NOS2NOS3GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-06-16 US disclosed
EP-0409484-B1 4,5,6,7-Tetrasubstituted benzoxazolones PFIZER (US) 1994-06-08 EP disclosed
US-5071863-A Antiallergens; antiinflammatory agents; enzyme inhibitors PFIZER INC. (US) 1991-12-10 US disclosed
EP-0409484-A2 4,5,6,7-Tetrasubstituted benzoxazolones PFIZER INC. (US) 1991-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE PTDSS1, PTDSS2, SMPD1 NOS1 1844/4885NOS2 2557/4885NOS3 2068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.